Výsledky vyhledávání - "Leon A. M. Frenken"

Renal Function of Pre-Dialysis Patients during Treatment with Recombinant Human Erythropoietin

Autor: Robert A.P. Koene, Leon A. M. Frenken

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e009a3962cb37bdcff1a1ad09bd4eb3
https://doi.org/10.1159/000419529

Zobrazit plný text záznamu

Treatment of Predialysis Patients with Recombinant Human Erythropoietin

Autor: J. F. M. Wetzels, G. Schrijver, H. E. Sluiter, Robert A.P. Koene, P. Michielsen, R. Verberckmoes, Leon A. M. Frenken

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55a61eed20bb692677944767e989eb76
https://doi.org/10.1159/000417900

Zobrazit plný text záznamu

Does Treatment of Predialysis Patients with Recombinant Human Erythropoietin Compromise Renal Function?

Autor: Leon A. M. Frenken, Robert A. P. Koene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5dc230758075e880fabf9381c3b0cac6
https://doi.org/10.1159/000419485

Zobrazit plný text záznamu

ROLE OF POLYMORPHIC Fc RECEPTOR Fc??RIIa IN CYTOKINE RELEASE AND ADVERSE EFFECTS OF MURINE IgG1 ANTI-CD3/T CELL RECEPTOR ANTIBODY (WT31)1

Autor: Wil J.M. Tax, Wim P. M. Tamboer, Cor W. M. Jacobs, Robert A.P. Koene, Leon A. M. Frenken

Publikováno v: Transplantation. 63:106-112

Anti-CD3 monoclonal antibody (mAb) OKT3 is immunosuppressive, but causes severe adverse effects during the first administration ("first-dose reaction"). These adverse effects are presumably caused by cytokine release that results from T-cell activati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c86461875a3b565b90b7ebc2c60e60e
https://doi.org/10.1097/00007890-199701150-00020

Zobrazit plný text záznamu

Intraperitoneal Administration of Recombinant Human Erythropoietin

Autor: Dirk G. Struijk, Robert A.P. Koene, Peter J.W. Coppens, Raymond T. Krediet, Leon A. M. Frenken, Roland G.W.L. Tiggeler

Publikováno v: Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 12:378-383

Objective To determine the efficacy and safety of intraperitoneal administration of recombinant human erythropoietin (rHuEPO) in continuous ambulatory peritoneal dialysis (CAPD) patients compared to subcutaneous rHuEPO. Design Prospective analysis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71192d00dea8d4a89c7dbc933270b728
https://doi.org/10.1177/089686089201200409

Zobrazit plný text záznamu

Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin

Autor: Jack F.M. Wetzels, Robert A.P. Koene, Leon A. M. Frenken, Henk E. Sluiter

Publikováno v: Kidney International. 41:384-387

Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin. Results from animal experiments have suggested that treatment with recombinant human erythropoietin (rHuEPO) causes changes in renal hemodynamics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ab0672ffcfa5680fb7a2b2647d3e6b
https://doi.org/10.1038/ki.1992.53

Zobrazit plný text záznamu

THE ROLE OF ANTIBODY ISOTYPE IN IFN-γ AND IL-2 PRODUCTION DURING ANTI-CD3-INDUCED T CELL PROLIFERATION

Autor: Leon A. M. Frenken, Wil J.M. Tax, Robert A.P. Koene

Publikováno v: Transplantation. 51:881-886

Murine anti-CD3 mAb of the IgG2a isotype are effective in the reversal of graft rejection. However, the first injection of these mAb causes a transient T cell activation in vivo, resulting in the release of cytokines that are held responsible for the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4abc75b03574c0fdd265d64569ad96a4
https://doi.org/10.1097/00007890-199104000-00028

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání